CONNECT WITH US
AI & Deeptech

AI & Deeptech

Scientists Use AI-Designed CRISPR to Make Disease-Resistant Rice

Singularity Hub logo

Published on

Add as a preferred source on Google
Scientists Use AI-Designed CRISPR to Make Disease-Resistant Rice

The versatile, open-source tool could democratize efforts to engineer healthier, higher-yielding crops.

In many cultures, if rice isn’t on the table, it’s not a full meal. Yet the crop is constantly under attack. Bacterial blight is one of rice’s most destructive diseases, causing yield losses up to 50 percent. One culprit, a microbe called Xoo, genetically hijacks the plant’s metabolism, coaxing it to release sugars that fuel the invader’s growth and spread. Xoo thrives; the plant dies.

Thanks to years of molecular sleuthing, scientists have mapped out the bacteria’s main genetic targets. And using the gene editor, CRISPR, it’s now possible to destroy those targets and thwart the bacteria’s antics.

But even with such a powerful tool, progress has been slow. Part of the problem is accessibility. Proprietary gene editors often “require licensing agreements for commercial use,” says Bing Yang at the University of Missouri.

Instead, his team turned to OpenCRISPR-1. Developed by California startup Profluent, the freely available AI-generated gene editor can edit cultured human cells like the original CRISPR. But the tool has barely been tested in plants, which have their own genetic quirks.

Yang’s team reworked the editor into a plant engineering machine. Their upgrades reliably shut down genes required for Xoo invasion with 90 percent efficiency or higher. The plants faithfully passed the edits to the next generation, paving the way for rice strains resistant to blight.

“Our work bridges AI-driven protein engineering with practical agricultural applications,” they wrote.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.